Toll‐like receptors (TLRs) are pattern recognition receptors that act as the innate immune system’s first line of defense by sensing invading pathogen through pathogen associated molecular patterns (PAMPs). TLRs are type I transmembrane receptors with an ectodomain consisting of 19–25 leucine rich repeats and a cytoplasmic toll/IL‐1 receptor/resistance domain. Evolutionarily conserved microbial or viral ligands such as lipotechoic acids, dsRNA, lipopolysaccharide, flagellin, ssRNA and unmethylated CpG motifs are recognized by TLR ectodomains 2, 3, 4, 5, 7 and 9, respectively. The mechanism by which TLRs recognize such a diverse set of ligands within the secondary structural motif of leucine rich repeat motifs remains to be solved. From our recent TLR3 ectodomain crystal structure, we have predicted several potential modes of dsRNA binding. In these studies we will present mutational analysis of our predicted sites. Stimulation assays on mutants allowed validation of whether the sites participate in dsRNA recognition. Direct binding assays of these mutants reveal altered dsRNA:TLR3 ectodomain interactions. From these studies we have revised our model of TLR3 recognition of dsRNA. Research supported by NIH Intramural Research and NIAID Biodefense Award.